• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗纤溶酶:被遗忘的丝氨酸蛋白酶抑制剂?

Antiplasmin: the forgotten serpin?

作者信息

Coughlin Paul B

机构信息

Australian Centre for Blood Diseases, Monash University, Prahran.

出版信息

FEBS J. 2005 Oct;272(19):4852-7. doi: 10.1111/j.1742-4658.2005.04881.x.

DOI:10.1111/j.1742-4658.2005.04881.x
PMID:16176259
Abstract

Much of the basic biochemistry of antiplasmin was described more than 20 years ago and yet it remains an enigmatic member of the serine protease inhibitor (serpin) family. It possesses all of the characteristics of other inhibitory serpins but in addition it has unique N- and C-terminal extensions which significantly modify its activities. The N-terminus serves as a substrate for Factor XIIIa leading to crosslinking and incorporation of antiplasmin into a clot as it is formed. Although free antiplasmin is an excellent inhibitor of plasmin, the fibrin bound form of the serpin appears to be the major regulator of clot lysis. The C-terminal portion of antiplasmin is highly conserved between species and contains several charged amino acids including four lysines with one of these at the C-terminus. This portion of the molecule mediates the initial interaction with plasmin and is a key component of antiplasmin's rapid and efficient inhibitory mechanism. Studies of mice with targeted deletion of antiplasmin have confirmed its importance as a major regulator of fibrinolysis and re-emphasized its value as a potential therapeutic target.

摘要

抗纤溶酶的许多基本生物化学特性在20多年前就已被描述,但它仍然是丝氨酸蛋白酶抑制剂(serpin)家族中一个神秘的成员。它具备其他抑制性丝氨酸蛋白酶抑制剂的所有特征,但此外它还有独特的N端和C端延伸结构,这些结构显著改变了它的活性。N端作为因子XIIIa的底物,导致抗纤溶酶在形成凝块时发生交联并融入凝块中。尽管游离的抗纤溶酶是纤溶酶的优秀抑制剂,但丝氨酸蛋白酶抑制剂的纤维蛋白结合形式似乎是凝块溶解的主要调节因子。抗纤溶酶的C端部分在物种间高度保守,包含几个带电荷的氨基酸,其中包括四个赖氨酸,其中一个位于C端。分子的这一部分介导了与纤溶酶的初始相互作用,是抗纤溶酶快速高效抑制机制的关键组成部分。对靶向缺失抗纤溶酶的小鼠的研究证实了它作为纤维蛋白溶解主要调节因子的重要性,并再次强调了它作为潜在治疗靶点的价值。

相似文献

1
Antiplasmin: the forgotten serpin?抗纤溶酶:被遗忘的丝氨酸蛋白酶抑制剂?
FEBS J. 2005 Oct;272(19):4852-7. doi: 10.1111/j.1742-4658.2005.04881.x.
2
X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin.纤溶酶抑制剂α2-抗纤溶酶的X射线晶体结构。
Blood. 2008 Feb 15;111(4):2049-52. doi: 10.1182/blood-2007-09-114215. Epub 2007 Dec 6.
3
Natural heterogeneity of α2-antiplasmin: functional and clinical consequences.α2-抗纤溶酶的天然异质性:功能和临床后果。
Blood. 2016 Feb 4;127(5):538-45. doi: 10.1182/blood-2015-09-670117. Epub 2015 Dec 1.
4
Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.α2-抗纤溶酶 C 末端保守赖氨酸残基对纤溶酶结合和抑制的贡献。
J Biol Chem. 2011 Jul 15;286(28):24544-52. doi: 10.1074/jbc.M111.229013. Epub 2011 May 4.
5
Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.鉴定抗纤溶酶中参与其与纤溶酶非共价“赖氨酸结合位点”依赖性相互作用的氨基酸。
Eur J Biochem. 2003 May;270(9):2023-9. doi: 10.1046/j.1432-1033.2003.03578.x.
6
Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.α2-抗纤溶酶恩斯赫德不是纤溶酶的抑制剂,而是其底物。
Biochem J. 1988 Oct 15;255(2):609-15.
7
A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice.小鼠体内α2-抗纤溶酶-蛋白酶复合物血浆清除的独特途径。
Thromb Haemost. 1982 Oct 29;48(2):208-10.
8
Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.苯乙二醛修饰的α2-抗纤溶酶对尿激酶诱导的纤维蛋白溶解的影响。
Thromb Haemost. 1998 Oct;80(4):637-44.
9
alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study.
Thromb Res. 2000 Aug 15;99(4):399-406. doi: 10.1016/s0049-3848(00)00261-9.
10
Purification of human alpha 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide.
Prep Biochem Biotechnol. 1997 Nov;27(4):227-37. doi: 10.1080/10826069708001281.

引用本文的文献

1
Fibrinolysis-Mediated Pathways in Acute Liver Injury.纤维蛋白溶解介导的急性肝损伤途径。
Semin Thromb Hemost. 2024 Jun;50(4):638-647. doi: 10.1055/s-0044-1779738. Epub 2024 Feb 23.
2
A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen.一种高通量小角 X 射线散射测定法,用于确定纤溶酶原构象变化。
Int J Mol Sci. 2023 Sep 19;24(18):14258. doi: 10.3390/ijms241814258.
3
Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease.
蛋白质组学方法及其在常染色体显性多囊肾病和法布里病中的潜在应用
Diagnostics (Basel). 2023 Mar 17;13(6):1152. doi: 10.3390/diagnostics13061152.
4
Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.健康与糖尿病中的纤溶酶抑制剂:该蛋白作为治疗靶点的作用
TH Open. 2022 Nov 18;6(4):e396-e407. doi: 10.1055/a-1957-6817. eCollection 2022 Oct.
5
Serpin-loaded extracellular vesicles promote tissue repair in a mouse model of impaired wound healing.载丝氨酸蛋白酶抑制剂的细胞外囊泡促进了伤口愈合受损小鼠模型中的组织修复。
J Nanobiotechnology. 2022 Nov 5;20(1):474. doi: 10.1186/s12951-022-01656-7.
6
Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.α2-抗纤溶酶:脑血管病和心血管病中你所不了解的“恶魔”
Front Cardiovasc Med. 2020 Dec 23;7:608899. doi: 10.3389/fcvm.2020.608899. eCollection 2020.
7
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study.深静脉血栓形成后患者血栓形成性血栓特性可预测静脉溃疡:一项队列研究。
J Thromb Thrombolysis. 2019 Nov;48(4):603-609. doi: 10.1007/s11239-019-01914-w.
8
X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors.氨甲环酸衍生的活性位点抑制剂与纤溶酶的X射线晶体结构
Blood Adv. 2017 May 9;1(12):766-771. doi: 10.1182/bloodadvances.2016004150.
9
Plasminogen-receptor : plasminogen activation and beyond.纤溶酶原受体:纤溶酶原激活及其他相关作用
J Thromb Haemost. 2017 Jan;15(1):150-154. doi: 10.1111/jth.13541. Epub 2016 Nov 25.
10
Rapid Increases in proBDNF after Pilocarpine-Induced Status Epilepticus in Mice Are Associated with Reduced proBDNF Cleavage Machinery.匹罗卡品诱导的癫痫持续状态后小鼠脑中 proBDNF 的快速增加与 proBDNF 裂解机制的减少有关。
eNeuro. 2016 Mar 30;3(1). doi: 10.1523/ENEURO.0020-15.2016. eCollection 2016 Jan-Feb.